Traders Bet Big on Bio-Techne Decline with Put Options Surge

Unusual options activity signals bearish sentiment on the biotech stock

Apr. 10, 2026 at 3:38pm

Got story updates? Submit your updates here. ›

An extreme close-up of complex, interlocking metal gears and machinery in shades of grey, bronze, and black, conceptually representing the intricate financial mechanics behind the surge in put option trading on Bio-Techne.The surge in put option trading on Bio-Techne suggests traders are positioning for potential downside in the biotech stock, signaling broader concerns about the industry.Minneapolis Today

Traders on Friday acquired a large volume of put options on Bio-Techne Corp (NASDAQ:TECH), signaling a bearish outlook on the biotech company's stock. The 10,003 put options purchased represented a 454% increase compared to the average daily volume, suggesting traders are positioning for a potential decline in the share price.

Why it matters

The surge in put option activity on Bio-Techne indicates that some traders are betting against the stock's performance, which could signal broader concerns about the company's outlook or the broader biotech sector. Put options are typically used to hedge against downside risk or to speculate on a stock's decline, so the unusual trading volume suggests traders see potential near-term weakness in the stock.

The details

The put options were purchased on Friday, with the 10,003 contracts representing a significant increase from the average daily volume of 1,804 put options. Put options give the holder the right to sell the underlying stock at a predetermined price, so the spike in put buying indicates traders are positioning for Bio-Techne's share price to fall.

  • The unusual options activity occurred on Friday, April 10, 2026.

The players

Bio-Techne Corp

A global life sciences company that develops, manufactures and sells high-quality reagents, instruments and services for the research, diagnostic and bioprocessing markets.

Got photos? Submit your photos here. ›

The takeaway

The significant increase in put option trading on Bio-Techne suggests that some investors are positioning for potential downside in the stock, which could reflect broader concerns about the company or the biotech industry. Traders will be closely watching the stock's performance in the coming days and weeks to see if the bearish sentiment is borne out.